Results 91 to 100 of about 5,025 (225)

Presentation of HIV‐Associated Thrombotic Microangiopathy and Response to Therapeutic Plasma Exchange: A 10‐year Retrospective Single‐Centre Cohort Study

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background HIV is a significant aetiological factor in thrombotic microangiopathy (TMA) in regions of high seroprevalence, but description of HIV‐associated TMA (HIV‐TMA) remains limited to small case series. We sought to describe the presentation, complications of TPE, and mortality and renal outcomes of HIV‐TMA.
Malcolm Davies   +4 more
wiley   +1 more source

Immune Thrombocytopenic Purpura Associated With Capnocytophaga Bacteremia

open access: yesAnnals of Internal Medicine: Clinical Cases
Capnocytophaga canimorsus is a gram-negative, capnophilic bacillus commonly found in the oral flora of healthy dogs and cats. C canimorsus can be transmitted to humans via animal bites, scratches, or close contact.
Patricia Zhao   +4 more
doaj   +1 more source

The effect of single nucleotide polymorphisms and mutations on congenital thrombotic thrombocytopenic purpura phenotype [PDF]

open access: yes, 2017
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disease with a reported incidence of 6 cases per million per year in the UK. It is characterised by episodes of microangiopathic haemolytic anaemia and thrombocytopenia, with the ...
Tate, H., Tate, H.
core  

Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation [PDF]

open access: yes, 2010
Background To report our experience of a rather uncommon drug interaction, resulting in hemolytic uremic syndrome (HUS). Methods Two consecutive cases of hemolytic uremic syndrome were diagnosed in our service.
Haralabos Parissis   +2 more
core   +2 more sources

Atypical haemolytic-uraemic syndrome caused by factor H mutation: case report and new management strategies in children [PDF]

open access: yes, 2012
Atypical haemolytic uraemic syndrome is causedby alternative complement pathway dysregulation. It has recently been recognised that most cases are due to genetic factors and a growing list of mutations has been described.
Araújo, L.   +5 more
core  

First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis. [PDF]

open access: yes, 2014
BackgroundAtypical hemolytic uremic syndrome (aHUS) is a rare and heterogeneous disorder. The first line treatment of aHUS is plasma therapy, but in the past few years, the recommendations have changed greatly with the advent of eculizumab, a humanized ...
A Szilagyi   +39 more
core   +1 more source

Consequences of CRISPR‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 6, March 2026.
ABSTRACT The integrity of the pancreatic islet microvasculature is critical for endocrine function, yet it is progressively compromised by glucotoxicity in diabetes. While matrix metalloproteinases are implicated, the role of stromelysin‐1 as a potential upstream driver of endothelial dysfunction remains poorly defined.
Bing Wang   +9 more
wiley   +1 more source

Thrombotic microangiopathies during pregnancy : The obstetrical and neonatal perspective [PDF]

open access: yes, 2019
Thrombotic Microangiopathies during pregnancy and puerperium are very rare and, if undiagnosed, can be lifethreating. Pregnancy and postpartum can represent a trigger in predisposed patients.
Martinelli, Pasquale   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy